Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant Help Center Crisis
Powered By
Real members of MyLungCancerTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

What is the latest sclc treatment just approved last fall

A MyLungCancerTeam Member asked a question 💭
61350
March 31, 2025
 · 
Be the first to react
A MyLungCancerTeam Member

I went through my first treatment was Esoposide, Carboplatin, Imfinzi, then just Imfinzi immunotherapy until found spots in brain did 10 sessions of whole brain therapy
Then switched to Zepzelca. Then went back to first treatment
of Carboplatin and Esoposide allowed the cancer in my liver grow by 20% so now looking at a new treatment just approved last fall by FDA and going on 4/4 for a consultation idk if this is the new treatment (lurbinectedin) I'm totally exhausted from chemotherapy. Good luck and God Bless 🙏

April 1, 2025
A MyLungCancerTeam Member

Randall, I'm just now seeing your question. If your question refers to Limited Stage SCLC, the answer is Durvalumab (Imfinzi). FDA finally approved it for Limited Stage on Dec. 4, 2024 and my first infusion was Dec. 11th. Tomorrow will be my 8th trip. Other than the expected fatigue and my thyroid numbers being a bit wonky, I've had other issues.

April 1, 2025
MyLungCancerTeam

Based on the provided search results, there are several recently approved treatments for lung cancer, but they appear to be primarily for NSCLC (Non-Small Cell Lung Cancer) rather than SCLC (Small Cell Lung Cancer).

For SCLC specifically, recent research has studied lurbinectedin, though results showed that while it had Show Full Answer

Based on the provided search results, there are several recently approved treatments for lung cancer, but they appear to be primarily for NSCLC (Non-Small Cell Lung Cancer) rather than SCLC (Small Cell Lung Cancer).

For SCLC specifically, recent research has studied lurbinectedin, though results showed that while it had fewer side effects than traditional treatments, it didn't demonstrate better outcomes. The standard treatment approach for SCLC continues to be chemotherapy (typically cisplatin or carboplatin plus etoposide), sometimes combined with immunotherapy depending on the cancer stage. For extensive-stage SCLC, doctors often recommend combining chemotherapy with immunotherapy as this combination has shown improved survival rates. If you're interested in newer treatment options, it's worth discussing clinical trials with your healthcare team, as research into new treatments is ongoing.

March 31, 2025

Related Questions

View All

Latest SCLC treatment

A MyLungCancerTeam Member asked a question 💭
61350
March 31, 2025

Am I the only one in here with a Small Cell Lung Cancer diagnosis?

A MyLungCancerTeam Member asked a question 💭
Kansas City, MO
March 17, 2024

Which has a better prognosis Sclc or non sclc

A MyLungCancerTeam Member asked a question 💭
Bath, UK
February 2

NSCLC Treatment Options: First-Line Treatments and Beyond
Wearable Device Approved To Treat Advanced NSCLC
5-Minute Rybrevant Injection Approved for EGFR-Positive NSCLC
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In